Cellebrite Expands Forensics Portfolio with Acquisition of Drone Forensics Leader SCG Canada
CLBT is trading near its 52-week low of $11.76 (11% above the low).
Summary
Cellebrite has completed its acquisition of SCG Canada, Inc., a recognized leader in drone forensics. This strategic move significantly expands Cellebrite's digital intelligence capabilities by integrating advanced drone data extraction and analysis into its existing portfolio. The acquisition positions Cellebrite to address the growing demand for forensic solutions in the rapidly evolving drone technology sector, enhancing its market leadership. Traders will be looking for further details on the financial terms of the acquisition and its anticipated impact on Cellebrite's revenue and market share.
At the time of this announcement, CLBT was trading at $13.11 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $11.76 to $20.86. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.